Tech entrepreneur Bryan Johnson aims for biological immortality by 2039, driven by AI’s acceleration of biotech and anti-aging therapies. He claims his “Blueprint” regimen has maintained his biological age, citing nature’s examples of agelessness. Johnson is developing organ clones for rapid drug testing, believing AI innovation makes this ambitious goal achievable.